SuperworthAEON Biopharma market cap AEON
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $12M
- Highest close in our data
- $585.3M
- Mar 2024
AEON Biopharma is worth $12M at the close on Oct 23, 2026, at $0.24 a share.
That is up 993% over the last year.
Its highest close in our data was $585.3M in Mar 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $12M | $6.6M | $26.6M | −1% |
| 2025 | $12.1M | $366.4K | $22.7M | −49% |
| 2024 | $23.6M | $21.2M | $585.3M | −91% |
| 2023 | $267.5M | $37.1M | $267.5M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest AEON Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| AEONAEON Biopharma | $12M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on AEON Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.